AU Patent
AU2008354558B2 — Stable ophthalmic formulations
Assigned to Medivis SRL · Expires 2013-07-25 · 13y expired
What this patent protects
Disclosed herein are stable formulations suitabel for the treatment of glaucoma and ocular hypertension.
USPTO Abstract
Disclosed herein are stable formulations suitabel for the treatment of glaucoma and ocular hypertension.
Drugs covered by this patent
- Xalatan (LATANOPROST) · Thea Pharma
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.